DSIP

DSIP (Delta Sleep–Inducing Peptide) 10mg is a naturally occurring neuropeptide fragment investigated in controlled models for its role in sleep–wake regulation, stress-response pathways, and neuroendocrine balance. Experimental literature evaluates DSIP’s influence on central nervous system activity, circadian architecture, and hypothalamic–pituitary axes in both in vitro and in vivo systems.

Per vial composition: DSIP 10 mg (lyophilized powder for reconstitution in research settings).

Sleep–Wake Modulation: DSIP is studied for its capacity to influence sleep architecture, including slow-wave and REM-associated patterns, via central neuropeptide and neurotransmitter pathways.
Neuroendocrine Effects: Research explores DSIP’s interaction with hypothalamic–pituitary signaling, including potential modulation of ACTH, cortisol, and other stress-related hormone outputs in experimental models.
Neurotransmitter & Neuromodulator Pathways: Experimental endpoints frequently monitor changes in GABAergic, glutamatergic, and monoaminergic tone, stress-related biomarkers, and circadian rhythm markers as readouts of DSIP-associated activity.

Sleep-architecture and circadian-rhythm models • Stress and HPA-axis frameworks • Neurotransmitter and neuromodulator assays • CNS excitability and arousal-state investigations • Behavioral studies evaluating restfulness, fatigue, and stress-adaptation responses • PK/PD profiling of DSIP and related neuropeptide analogs in preclinical systems.

Revitalized Health research peptides are produced under cGMP-aligned conditions with pharmaceutical-grade raw materials. Each DSIP 10mg lot is confirmed at ≥99% purity by HPLC, with peptide identity verified via LC-MS/MS. Lots undergo visual inspection, solubility verification, and microbial/endotoxin screening to ensure research-grade performance. Batch-specific Certificates of Analysis provide full analytical methodology and results for traceability.

Store lyophilized DSIP 10mg vials at 2–8 °C, protected from light and moisture. After reconstitution with bacteriostatic water, maintain at 2–8 °C and utilize within 20 days. Avoid repeated freeze–thaw cycles to preserve peptide structural integrity and experimental consistency.

For laboratory research use only. Not intended for human consumption, therapeutic, or diagnostic application. Supplied exclusively to qualified professionals conducting controlled scientific investigations.

Identity: DSIP (Delta Sleep–Inducing Peptide), a neuropeptide researched for its role in sleep–wake regulation, stress responses, and autonomic balance. Supplied as a 10mg lyophilized research vial.

Mode:
• Investigated for modulation of sleep architecture with emphasis on slow-wave sleep (SWS) and sleep latency in controlled models.
• Preclinical literature evaluates interactions with GABAergic, serotonergic, and stress-axis pathways, including effects on corticotropin-related signaling and autonomic tone.
• Experimental frameworks examine changes in EEG patterns, circadian markers, and resilience to stressors in laboratory settings.

Analytics: HPLC purity; LC-MS/MS identity; peptide content verification; endotoxin testing via LAL; appearance/solubility checks under research conditions.
PD readouts: EEG-based sleep staging, onset/maintenance metrics, cortisol and HPA-axis markers, heart-rate variability, and behavioral sleep–wake scoring in model systems.
Monitoring (research): sedation level, next-day performance metrics, autonomic markers, and local injection-site tolerance.